Comparison of 4-Hydroxynonenal-induced P53-mediated apoptosis in prostate cancer cells LNCaP and DU145

Wspolczesna Onkologia

Volumn 18, Issue 1, 2014, Pages 22-28

  Cao, Zhi Gang ^a   Xu, Xu ^a   Xue, Ye Min ^b   Zhao, Shu Li ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

Author keywords

4 Hydroxynonenal; Glutathione S transferase; P53 signal pathway; Prostate cancer

Indexed keywords

4 HYDROXYNONENAL; ANDROGEN; CASPASE 3; GLUTATHIONE TRANSFERASE A4; PROTEIN BAX; PROTEIN P21; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PROSTATE CANCER; TUMOR CELL LINE;

EID: 84898465803     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2014.40456     Document Type: Article

References (40)

1. Haag P, Bektic J, Bartsch G, Klocker H, Eder IE. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. Steroid Biochem Mol Biol 2005; 96: 251-8.
2. Davarci M, Gokce A, Guven EO, Yalcinkaya FR, Esen H, Sevinc A. Metastatic prostate adenocarcinoma presenting as supraclavicular lymphadenopathy: a report of two cases. Wspolczesna Onkol 2012; 16: 53-5.
3. Zhang SG, Wang YH, Ding Y, Wu Y. Long term survival results in advanced prostate cancer treated with combined androgen. Zhonghua Nan Ke Xue 2005; 11: 770-4.
4. Cieśliński P, Hojan-Osicka M, Antczak A, Kwias Z. Assessment of intraoperative and postoperative complications during implementation of laparoscopic radical prostatectomy in patients with locally advanced prostate cancer. Wspolczesna Onkol 2011; 15: 372-5.
5. Zaborowska M, Szmit S, Szczylik C. Sorafenib in progressive castrate- resistant prostate cancer. Can we talk about a new therapeutic option? Arch Med Sci 2012; 8: 528-32.
6. Kawalec P, Paszulewicz A, Holko P, Pilc A. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. Arch Med Sci 2012; 8: 767-75.
7. Ziołkowska E, Zarzycka M, Wiśniewski T, Zyromska A. The side effects of hormonal therapy at the patients with carcinoma of prostate cancer. Wspolczesna Onkol 2012; 16: 491-7.
8. Kulik A, Da̧bkowski M. Prostate cancer radiotherapy. Wspolczesna Onkol 2011; 15: 317-22.
9. Tam NN, Gao Y, Leung YK, Ho SM. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 2003; 163: 2513-22.
10. Usatyuk PV, Natarajan V. Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J Biol Chem 2004; 279: 11789-97.
11. Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 2005; 280: 41921-7.
12. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal 2003; 15: 355-66.
13. Cheng JZ, Sharma R, Yang Y, et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001; 276: 41213-23.
14. Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, Awasthi S, Awasthi YC. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem 2003; 278: 41380-8.
15. Sharma R, Brown D, Awasthi S, et al. Transfection with 4-hydroxynonenal- metabolizing glutathione S-transferase isozymes leads to phenotypic transformation and immortalization of adherent cells. Eur J Biochem 2004; 271: 1690-701.
16. Patrick B, Li J, Jeyabal PV, et al. Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression. Biochem Biophys Res Commun 2005; 334: 425-2.
17. Cheng JZ, Singhal SS, Saini M, et al. Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells. Arch Biochem Biophys 1999; 372: 29-36.
18. Alshagga MA, Mohamed N, Nazrun Suhid A, Abdel Aziz Ibrahim I, Zulkifli Syed Zakaria S. Frequencies of glutathione s-transferase (GSTM1, GSTM3 AND GSTT1) polymorphisms in a Malaysian population. Arch Med Sci 2011; 7: 572-8.
19. Cheng JZ, Sharma R, Yang Y, et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001; 276: 41213-23.
20. Awasthi YC, Yang Y, Tiwari NK, Patrick B, Sharma A, Li J, Awasthi S. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic Biol Med 2004; 37: 607-19.
21. Liu W, Kato M, Akhand AA, et al. 4-Hydroxynonenal induces a cellular redox status-related activation of caspase cascade for apoptotic cell death. J Cell Sci 2000; 113: 635-41.
22. Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli G, Dianzani MU. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16: 1014-21.
23. Li J, Sharma R, Patrick B, et al. Regulation of CD95 (Fas) expression and Fas-mediated apoptotic signaling in HLEB-3 cells by 4-hydroxynonenal. Biochemistry 2006; 45: 12253-64.
24. Laurora S, Tamagno E, Briatore F, et al. 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radic Biol Med 2005; 38: 215-25.
25. Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, Awasthi S, Awasthi YC. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem 2003; 278: 41380-8.
26. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. J Biol Chem 1999; 274: 2234-42.
27. Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G. C-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med 2006; 41: 443-54.
28. Nanji AA, Zhao S, Sadrzadeh SM, Dannenberg AJ, Tahan SR, Waxman DJ. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin Exp Res 1994; 18: 1280-5.
29. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 1997; 11: 3471-81.
30. Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997; 89(1):40-48
31. Fleshner NE, Klotz LH. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1998-1999; 17: 325-30.
32. Fair WR, Fleshner NE, Heston W. Cancer of the prostate: a nutritional disease. Urology 1997; 50: 840-8.
33. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993; 118: 793-803.
34. Yang Y, Sharma R, Sharma A, Awasthi S, Awasthi YC. Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 2003; 50: 319-36.
35. Jacobs AT, Marnett LJ. HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 2009; 284: 9176-83.
36. Sharma A, Sharma R, Chaudhary P, et al. 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells. Arch Biochem Biophys 2008; 480: 85-94.
37. Pettazzoni P, Ciamporcero E, Medana C, et al. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. Free Radic Biol Med 2011; 51: 1610-8.
38. Yang Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, Awasthi S, Awasthi YC. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem 2003; 278: 41380-8.
39. Cheng JZ, Sharma R, Yang Y, et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001; 276: 41213-23.
40. Sharma R, Sharma A, Dwivedi S, Zimniak P, Awasthi S, Awasthi YC. 4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. Biochem 2008; 47: 143-56.